A Multicentre, Double-Blind, Randomized, Placebo Controlled, Parallel group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (DESTINATION)
- Gillman, Andrew, (Primary Chief Investigator (PCI))
- Hazard, Anita (Project Manager)
- Thompson, Katherine, (Project Manager)
Project: Research